1-3 of 3
Susan Bakke
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Study of the P-Glycoprotein Antagonist Tariquidar in Combination with Vinorelbine

Jame Abraham, Maureen Edgerly, Richard Wilson, Clara Chen, Ann Rutt, Susan Bakke, Rob Robey, Andrew Dwyer, Barry Goldspiel, Frank Balis, Olaf Van Tellingen, Susan E. Bates, Tito Fojo
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (10): 3574–3582.
https://doi.org/10.1158/1078-0432.CCR-08-0938
Published: 18 May 2009
View article titled, A Phase I Study of the P-Glycoprotein Antagonist Tariquidar in Combination with Vinorelbine
Open the PDF for A Phase I Study of the P-Glycoprotein Antagonist Tariquidar in Combination with Vinorelbine in another window
Includes: Supplementary data
Journal Articles

A Phase I/II Study of Infusional Vinblastine with the P-Glycoprotein Antagonist Valspodar (PSC 833) in Renal Cell Carcinoma

Susan E. Bates, Susan Bakke, Min Kang, Robert W. Robey, Suoping Zhai, Paul Thambi, Clara C. Chen, Sheela Patil, Tom Smith, Seth M. Steinberg, Maria Merino, Barry Goldspiel, Beverly Meadows, Wilfred D. Stein, Peter Choyke, Frank Balis, William D. Figg, Tito Fojo
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (14): 4724–4733.
https://doi.org/10.1158/1078-0432.CCR-0829-03
Published: 21 July 2004
View article titled, A Phase I/II Study of Infusional Vinblastine with the P-Glycoprotein Antagonist Valspodar (PSC 833) in Renal Cell Carcinoma
Open the PDF for A Phase I/II Study of Infusional Vinblastine with the P-Glycoprotein Antagonist Valspodar (PSC 833) in Renal Cell Carcinoma in another window
Journal Articles

Phase I Trial of the Histone Deacetylase Inhibitor, Depsipeptide (FR901228, NSC 630176), in Patients with Refractory Neoplasms

Victor Sandor, Susan Bakke, Robert W. Robey, Min H. Kang, Mikhail V. Blagosklonny, Jonathon Bender, Rebecca Brooks, Richard L. Piekarz, Eben Tucker, William D. Figg, Kenneth K. Chan, Barry Goldspiel, Antonio Tito Fojo, Stanley P. Balcerzak, Susan E. Bates
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (3): 718–728.
Published: 01 March 2002
View article titled, Phase I Trial of the Histone Deacetylase Inhibitor, Depsipeptide (FR901228, NSC 630176), in Patients with Refractory Neoplasms
Open the PDF for Phase I Trial of the Histone Deacetylase Inhibitor, Depsipeptide (FR901228, NSC 630176), in Patients with Refractory Neoplasms in another window